| Szabo, Eva |
| Active, not recruiting | 3 | 2158 | Europe, US, RoW | IBP-9414, Placebo | Infant Bacterial Therapeutics | Necrotizing Enterocolitis | 06/24 | 07/24 | | |
NCT04460352: Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer |
|
|
| Recruiting | 3 | 1020 | Europe, Canada | Neoadjuvant radiotherapy (arm A), Carboplatin, paclitaxel, Neoadjuvant chemotherapy, Esophagectomy, Neoadjuvant radiotherapy (arm B), Neoadjuvant Platin-Taxane Regimen (alternative 1), Cisplatin, paclitaxel, Platinum-Fluoropyrimidine Regimens (alternative 2a), Oxaliplatin, calcium folinate, 5-fluorouracil, Platinum-Fluoropyrimidine Regimens (alternative 2b) | Karolinska University Hospital, University of Leipzig, The Swedish Research Council | Esophageal Squamous Cell Carcinoma | 09/26 | 12/31 | | |
| Not yet recruiting | 3 | 952 | Europe | Surveillance protocol | University of Dublin, Trinity College, Trinity St. James's Cancer Institute, University of Oxford, Karolinska Institutet | Esophageal Cancer, Gastric Cancer | 11/26 | 11/29 | | |
| Knutsson, Johan |
| Completed | N/A | 49 | Europe | | Region Örebro County | Oral Cancer | 03/24 | 03/24 | | |
| Fengsrud, Espen |
NCT05939076: First-line Cryoablation for Early Treatment of Persistent Atrial Fibrillation |
|
|
| Not yet recruiting | 3 | 220 | Europe | Pulmonary vein isolation, dronedarone - Multaq™ OR flecainide - Tambocor™ OR propafenone - Rytmonorm™ OR sotalol - Sotacor™ | Region Örebro County, The Swedish Research Council, Erling-Persson Stiftelse, Swedish Heart Lung Foundation, Uppsala University | Atrial Fibrillation, Persistent | 12/27 | 12/28 | | |
| Linde, Peter |
NCT05891366: Single Ascending Dose Study of WAL0921 in Healthy Subjects |
|
|
| Completed | 1 | 40 | US | WAL0921, Placebo | Walden Biosciences | Healthy | 01/24 | 01/24 | | |
| Andersson, Tommy |
| Recruiting | N/A | 2000 | Europe, US, RoW | EmboTrap® Revascularization Device, CERENOVUS Large Bore Catheter/ EMBOVAC Aspiration Catheter, CEREGLIDE 71 Intermediate Catheter | Cerenovus, Part of DePuy Synthes Products, Inc. | Cerebral Stroke | 03/25 | 06/25 | | |
| Recruiting | N/A | 2000 | Europe, US, RoW | EmboTrap® Revascularization Device, CERENOVUS Large Bore Catheter/ EMBOVAC Aspiration Catheter | Cerenovus, Part of DePuy Synthes Products, Inc. | Cerebral Stroke | 07/24 | 10/24 | | |
| Christiansen, Evald H |
NCT02623140: BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX |
|
|
| Active, not recruiting | 4 | 3150 | Europe | Biofreedom, Orsiro | Odense University Hospital, Aarhus University Hospital Skejby, Aalborg University Hospital, Rigshospitalet, Denmark | Ischaemic Heart Disease | 10/18 | 10/23 | | |
NCT01496651: PCI vs. CABG in the Treatment of Unprotected Left Main Stenosis |
|
|
| Active, not recruiting | N/A | 1201 | Europe | Percutaneous coronary intervention, PCI, PTCA, Coronary artery bypass graft operation, CABG | Evald Hoej Christiansen | Coronary Artery Disease | 01/15 | 12/25 | | |
| Active, not recruiting | N/A | 160 | Europe | Everolimus eluting bioresorbable polymer stent, SYNERGY, Biolimus eluting bioresorbable polymer stent, Biomatrix NeoFlex | Aarhus University Hospital Skejby, Biosensors International, Boston Scientific Corporation | Coronary Artery Disease, Angina Pectoris, Myocardial Infarction | 04/15 | 12/25 | | |
| Active, not recruiting | N/A | 20 | Europe | Magmaris | Aarhus University Hospital Skejby | Coronary Artery Disease | 08/19 | 12/24 | | |
NOTION-2, NCT02825134: Comparison of TAVR With SAVR in Younger Low Surgical Risk Patients With Severe Aortic Stenosis |
|
|
| Active, not recruiting | N/A | 376 | Europe, RoW | Transcatheter aortic valve replacement, Transcatheter aortic valve implantation, TAVR, TAVI, Surgical aortic valve replacement, SAVR | Ole De Backer, Symetis SA, Boston Scientific Corporation, Abbott, Edwards Lifesciences | Aortic Valve Stenosis, Cardiovascular Diseases, Heart Diseases, Heart Valve Diseases, Ventricular Outflow Obstruction | 02/24 | 06/29 | | |
OCTOBER, NCT03171311: The Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction |
|
|
| Active, not recruiting | N/A | 1201 | Europe | Angiographic guided PCI, PCI, percutaneous transluminal coronary angioplasty (PTCA), OCT guided PCI, OCT | Aarhus University Hospital Skejby, Abbott | Ischaemic Heart Disease, Ischemic Heart Disease | 03/22 | 05/29 | | |
| Active, not recruiting | N/A | 3141 | Europe | PCI with BioMatrix Alpha™ stent, Biolimus eluting absorbable polymer coated BioMatrix Alpha™ stent, PCI with Combo™ stent, Combined sirolimus eluting and endothelial progenitor cell Combo™ stent | Phillip Freeman, Aarhus University Hospital, Odense University Hospital, OrbusNeich, Biosensors International | Coronary Artery Disease | 03/23 | 11/30 | | |
| Active, not recruiting | N/A | 2001 | Europe | QFR-based diagnostic strategy, FFR-based diagnostic strategy | Aarhus University Hospital Skejby, Medis Medical Imaging Systems | Coronary Artery Disease | 07/23 | 12/25 | | |
FLOW3, NCT04973410: The Association Between Catheter-based Absolute Coronary Flow and Resistance and 15O-H2O Positron Emission Tomography Scan Based Absolute Myocardial Blood Flow in the Coronary Artery Territory |
|
|
| Active, not recruiting | N/A | 40 | Europe | Coronary Physiology, IMR, FFR, CFR, 15O-H2O-PET scan | Aarhus University Hospital Skejby, Department of Nuclear Medicine, Aarhus University Hospital | Coronary Artery Disease | 12/23 | 12/24 | | |
BALI, NCT04253171: Balloon Lithoplasty for Preparation of Severely Calcified Coronary Lesions |
|
|
| Active, not recruiting | N/A | 200 | Europe | Lithoplasty, Shockwave, Lithotripsy, Conventional | Herlev and Gentofte Hospital, Abbott | Percutaneous Coronary Intervention, Coronary Artery Calcification, Coronary Artery Disease | 09/25 | 01/27 | | |
BIFSORB, NCT02973529: The Bioresorbable Implants for Scaffolding Obstructions in Randomized Bifurcations () Study |
|
|
| Active, not recruiting | N/A | 120 | Europe | Absorb, Desolve | Aarhus University Hospital Skejby | Coronary Artery Disease | 11/26 | 09/28 | | |
| Recruiting | N/A | 1560 | Europe | Percuteneous Coronary Intervention, Optimal Medical Therapy | Aarhus University Hospital Skejby | Ischemic Heart Disease, Chronic Total Occlusion of Coronary Artery | 11/28 | 11/32 | | |
| Fröbert, Ole |
| Recruiting | 4 | 1700 | Europe | Metoprolol, Standard care, Usual standard care | Ole Frobert, MD, PhD | Chronic Obstructive Pulmonary Disease | 12/24 | 12/24 | | |
| Completed | N/A | 24 | Europe | Examination and analysis of sweat and blood samples at baseline and at follow up, Examination and analysis of sweat and blood samples at baseline | Region Örebro County, University Hospital, Basel, Switzerland | Acute Myocardial Infarction | 03/23 | 03/23 | | |
NCT04562805: Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT) |
|
|
| Active, not recruiting | N/A | 2400 | Europe | DynamX Bioadaptor, Resolute Onyx | Elixir Medical Corporation, Uppsala University | Coronary Artery Disease, Ischemic Heart Disease | 08/24 | 07/28 | | |
| Recruiting | N/A | 30 | Europe | Thermotherapy | Region Örebro County | Cardiac Disease, Cardiac Rehabilitation | 12/24 | 12/25 | | |
| Recruiting | N/A | 22000 | Europe | Urea breath test | Karolinska Institutet, The Swedish Research Council, Swedish Heart Lung Foundation, Region Stockholm | Myocardial Infarction, Helicobacter Pylori Infection, GastroIntestinal Bleeding, Cardiovascular Diseases | 01/25 | 01/30 | | |
| Gupta, Anil |
NCT06261957: A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants 12 Years of Age and Older With Asthma |
|
|
| Recruiting | 3 | 412 | Europe, Canada, US, RoW | Salbutamol HFA-134a, Salbutamol HFA-152a | GlaxoSmithKline | Asthma | 04/25 | 04/25 | | |
SURMOUNT-5, NCT05822830: A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities |
|
|
| Active, not recruiting | 3 | 700 | US | Tirzepatide, LY3298176, Semaglutide | Eli Lilly and Company | Obesity, Overweight | 11/24 | 11/24 | | |
BRAIN-AF, NCT02387229: Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF |
|
|
| Terminated | 3 | 1238 | Canada | Rivaroxaban, Xarelto, standard of care | Montreal Heart Institute, Canadian Stroke Prevention Intervention Network, The Montreal Health Innovations Coordinating Center (MHICC), Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma, Montreal Heart Institute Foundation, Canadian Institutes of Health Research (CIHR), Hewitt Foundation | ATRIAL FIBRILLATION | 05/24 | 05/24 | | |
| Active, not recruiting | 3 | 15374 | Europe, Canada, Japan, US, RoW | Tirzepatide, LY3298176, Placebo | Eli Lilly and Company | Obesity, Overweight | 10/27 | 10/27 | | |
| Recruiting | 2 | 400 | Europe, Canada, RoW | semaglutide, Ozempic | Vladimír Džavík, Unity Health Toronto, Canadian Institutes of Health Research (CIHR), University of Toronto | Covid19, Myocardial Injury | 03/22 | 03/22 | | |
NCT05891834: Study of INV-202 in Patients With Obesity and Metabolic Syndrome |
|
|
| Active, not recruiting | 2 | 243 | Canada | INV-202, Placebo | Inversago Pharma Inc. | Obesity, Metabolic Syndrome | 07/24 | 03/25 | | |
MARS-17, NCT05838742: A Dose-Finding Study to Evaluate the Efficacy and Safety of GSK3858279 in Adults With Knee Osteoarthritis Pain |
|
|
| Recruiting | 2 | 420 | Europe, Canada, Japan, US, RoW | GSK3858279, Placebo | GlaxoSmithKline | Pain | 07/25 | 10/25 | | |
NCT05936151: A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes |
|
|
| Recruiting | 2 | 120 | Europe, Canada, US | LY3437943, Placebo | Eli Lilly and Company | Overweight or Obesity, CKD, Type 2 Diabetes | 11/25 | 11/25 | | |
| Completed | N/A | 450 | Europe | | Karolinska Institutet, Karolinska University Hospital | Myocardial Injury, Surgery--Complications | 03/23 | 06/23 | | |
| Recruiting | N/A | 12500 | Europe, Canada, US, RoW | | Arthrex, Inc. | Degenerative and Traumatic Pathology of the Knee, Degenerative and Traumatic Pathology of the Shoulder and Elbow, Degenerative and Traumatic Pathology of the Foot and Ankle, Degenerative and Traumatic Pathology of the Hand and Wrist, Degenerative and Traumatic Pathology of the Hip | 06/23 | 06/23 | | |
| Nilsson, Ulrica |
POCOR, NCT05564195: Cognitive Trajectories After Surgery, a Clinical, Observational Feasibility Study |
|
|
| Recruiting | N/A | 50 | Europe | Postoperative cognitive function | Karolinska Institutet, Ersta Hospital, Sweden | Postoperative Cognitive Dysfunction | 07/24 | 07/24 | | |
| Jendle, Johan |
NCT04230655: Weight Loss in Adults With Obesity Using a Combination of Low Energy Diet, Group Treatment and Intragastric Balloon |
|
|
| Recruiting | N/A | 110 | Europe | Low energy diet using meal replacements, LED, CBT-based group treatment, CBT, Intragastric balloon, IGB | Region Örebro County | Obesity, Weight Loss, Non-Alcoholic Fatty Liver Disease | 12/22 | 12/22 | | |
| Completed | N/A | 34 | Europe | InPen with Guardian 4 System | Medtronic Diabetes | Diabetes Type 1 | 12/23 | 12/23 | | |
| Torsello, Giovanni |
INSIGHT, NCT02477111: European (EU) Post Approval Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms |
|
|
| Completed | N/A | 150 | Europe | Endovascular abdominal aortic aneurysm repair | Cordis Corporation | Abdominal Aortic Aneurysms | 10/16 | 12/21 | | |
EMINENT, NCT02921230: Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery |
|
|
| Active, not recruiting | N/A | 775 | Europe | Peripheral stenting | Boston Scientific Corporation | Arterial Occlusive Diseases, Atherosclerosis, Vascular Diseases, Arteriosclerosis | 07/21 | 04/25 | | |
| Active, not recruiting | N/A | 58 | Europe | MOTIV BVS | Dr. Sabrina Overhagen | Peripheral Arterial Disease, Critical Limb Ischemia | 07/22 | 07/24 | | |
NCT04822727: AndraTec PMCF Study : Investigating the AndraTec Guidewires,PTA Balloons and Stents in Iliac Disease. |
|
|
| Withdrawn | N/A | 200 | NA | 1 or more AndraTec devices (see description for list of devices) | Dr. Sabrina Overhagen | Iliac Artery Disease, Peripheral Artery Disease | 12/22 | 12/23 | | |
| Recruiting | N/A | 204 | Europe | ESAR treatment: Endograft + Heli-FX Endoanchor, FEVAR treatment : Fenestrated endograft | FCRE (Foundation for Cardiovascular Research and Education), Medtronic | Aortic Aneurysm, Abdominal | 06/26 | 06/28 | | |
| Recruiting | N/A | 1000 | Europe, US | Thoracic, Abdominal, Custom Device, Illiac Artery | Vascutek Ltd., Bolton Medical | Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, Surgery | 11/29 | 11/30 | | |
| Bejerot, Susanne |
| Recruiting | 2 | 120 | Europe | Rituximab, Saline | Region Örebro County | Schizophrenia Spectrum and Other Psychotic Disorders | 06/26 | 12/26 | | |
NCT05557617: Periodontitis and Periodontal Bacteria in Dementia |
|
|
| Active, not recruiting | N/A | 120 | Europe | | Region Örebro County | Alzheimer Disease, Dementia, Periodontitis | 12/24 | 12/24 | | |
| Kellerth, Thomas |
NCT03642509: Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation |
|
|
| Recruiting | N/A | 750 | Europe | Left atrial appendage occlusion, Left atrial appendage closure, NOAC, Edoxaban, Apixaban, Rivaroxaban, Dabigatran | University of Aarhus, Aarhus University Hospital, Aalborg University Hospital, Odense University Hospital, Sahlgrenska University Hospital, Sweden, Karolinska University Hospital, Haukeland University Hospital, Helsinki University Central Hospital, Gødstrup Hospital, Lund University Hospital, Oslo University Hospital, Trondheim University Hospital, Rigshospitalet, Denmark, Jena University Hospital | Atrial Fibrillation, Stroke | 01/26 | 10/30 | | |
| Gebre-Medhin, Maria |
ARTSCAN VI, NCT06248996: a Multicentre Phase III Study of Risk-based Treatment Intensification With Hyperfractionated Radiotherapy in Head and Neck Cancer Patients |
|
|
| Recruiting | 3 | 308 | Europe | Hyperfractionated radiotherpy, HFX-RT, Control group, standard treatment | Lund University Hospital | Head and Neck Squamous Cell Carcinoma | 03/28 | 03/33 | | |
| Recruiting | N/A | 100 | Europe | Radiotherapy | Lund University Hospital | Tonsil Cancer | 01/28 | 01/28 | | |
| Brummer, Robert J |
NCT03918330: Spatial Analysis of the Intestinal Microbiota in Healthy Subjects |
|
|
| Active, not recruiting | N/A | 10 | Europe | | Örebro University, Sweden, Region Örebro County | Healthy Subjects | 02/19 | 12/24 | | |
NCT03920410: Effect of Serotonergic Stimulation on the Gut-brain Axis |
|
|
| Active, not recruiting | N/A | 58 | Europe | serotonergic stimulation, no serotonergic stimulation | Örebro University, Sweden, Region Örebro County | Healthy, Irritable Bowel Syndrome | 03/22 | 12/24 | | |
NCT05058131: Modulation of Intestinal Barrier Function and Inflammation Via Butyrate-promoting Dietary Fibre |
|
|
| Recruiting | N/A | 40 | Europe | Dietary fibre, Placebo compound | Örebro University, Sweden | Microscopic Colitis | 12/22 | 12/22 | | |
NCT05611138: Dietary Proteins: Metagenomic and Metabolomics Approaches for Human Biomarkers Identification |
|
|
| Completed | N/A | 59 | Europe | Protein supplementation | Örebro University, Sweden | Healthy | 04/23 | 04/23 | | |
NCT05421793: Prebiotic and Anti-inflammatory Effects of a Pectin Polysaccharide |
|
|
| Completed | N/A | 17 | Europe | Fermented product of carrot derived rhamnogalacturonan I | Örebro University, Sweden, NutriLeads B.V. (Wageningen, The Netherlands) | Healthy | 07/23 | 08/23 | | |
NCT05801042: Effect of Encapsulated vs Free Probiotic on Brain Function |
|
|
| Active, not recruiting | N/A | 90 | Europe | Maltodextrin, Encapsulated Lactocaseibacillus rhamnosus, Non-encapsulated Lactocaseibacillus rhamnosus | Robert Brummer | Aging | 11/23 | 09/24 | | |
| Recruiting | N/A | 11 | Europe | Oat Protein, low bioavailability, Oat Protein, high bioavailability, Pea Protein, low bioavailability, Pea Protein, high bioavailability, Protein-free meal | Örebro University, Sweden | Ileostomy - Stoma | 12/24 | 12/24 | | |
| Recruiting | N/A | 75 | Europe | Maltodextrin, Chicory RG-I, Carrot RG-I | Örebro University, Sweden, NutriLeads B.V. (Wageningen, The Netherlands), ProDigest (Ghent, Belgium), Ambiotis (Toulouse, France) | Healthy | 04/24 | 12/24 | | |
| Active, not recruiting | N/A | 28 | Europe | Isolated Pea Protein, Isolated Whey Protein, Isolated Faba Bean Protein, Placebo | Örebro University, Sweden | Healthy | 05/24 | 05/24 | | |
| Enrolling by invitation | N/A | 120 | Europe | | Örebro University, Sweden, VHIR, Aston University, Region Örebro County | Parkinson Disease, Irritable Bowel Syndrome | 10/27 | 10/27 | | |
| Tegnelius, Daniel |
SENOMIC, NCT02049632: Sentinel Node Biopsy in Breast Cancner: Omission of Axillary Clearance After Micrometastasis |
|
|
| Completed | N/A | 805 | Europe | Omission of axillary clearance | Karolinska Institutet, Centrallasarettet Västerås, Uppsala University | Breast Cancer | 12/22 | 12/22 | | |
| Loman, Niklas |
| Recruiting | 3 | 920 | Europe | epirubicin, cyclophosphamide, paclitaxel, carboplatin, pembrolizumab, anthracycline, taxane, platinum, epirubicin, cyclophosphamide, capecitabine, paclitaxel, carboplatin, pembrolizumab, anthracycline, taxane, antimetabolite, platinum | Lund University Hospital, Swedish Breast Cancer Group, Danish Breast Cancer Cooperative Group, Finnish Breast Cancer Group, Icelandic Breast Cancer Group | Breast Cancer, Triple Negative Breast Neoplasms | 06/23 | 06/35 | | |
| Not yet recruiting | 3 | 3832 | Europe | Letrozole, Anastrozole, Exemestane, Tamoxifen | Region Örebro County, Mid-Sweden Regional Cancer Centre, Akademiska University Hospital, Uppsala, Sweden | Breast Cancer | 05/32 | 05/35 | | |
| Recruiting | 3 | 500 | Europe | Triptorelin Embonate, Pamorelin, Sodium Chloride solution 0.9%, Placebo | Kenny Rodriguez-Wallberg | Breast Cancer Female, Acute Leukemia, Lymphoma, Osteosarcoma, Soft Tissue Sarcoma, Ewing Sarcoma | 01/28 | 01/32 | | |
SCAN-B, NCT02306096: Sweden Cancerome Analysis Network - Breast : Genomic Profiling of Breast Cancer |
|
|
| Recruiting | N/A | 20000 | Europe | | Lund University, South Sweden Breast Cancer Group, Mrs. Berta Kamprad Foundation, U-CAN | Breast Neoplasms | 08/31 | 08/31 | | |
| Larzon, Thomas |
| Active, not recruiting | N/A | 500 | Europe | Minimally-Invasive Segmental Artery Coil-Embolization | University of Leipzig, European Commission, German Research Foundation, Universidad de Granada, European Clinical Research Infrastructure Network, Modus Research and Innovation Limited, Rigshospitalet, Denmark, European Society of Cardiology, Baylor College of Medicine, University of Pennsylvania | Aortic Aneurysm, Thoracoabdominal | 06/25 | 06/25 | | |
| Deneberg, Stefan |
| Recruiting | 1 | 9 | Europe | Karonudib | Thomas Helleday Foundation | Leukemia | 01/26 | 01/26 | | |
| Jarl, Gustav |
NCT04085926: Sealed Therapeutic Shoe as Treatment of Diabetic Foot Ulcers |
|
|
| Recruiting | N/A | 150 | Europe | Sealed therapeutic shoe, Total contact cast | Region Örebro County, Stiftelsen Promobila, Forte | Diabetic Foot | 12/25 | 12/27 | | |
| Näslund, Ingemar |
| Recruiting | N/A | 25000 | Europe | Gastric bypass | Uppsala University, Karolinska Institutet, The Scandinavian Obesity Surgery Registry | Severe Obesity | 01/25 | 01/25 | | |
| Savilampi, Johanna |
NCT04885491: A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in COVID-19 Patients With Acute Pulmonary Hypertension |
|
|
| Withdrawn | 1/2 | 16 | Europe | Sodium chloride (placebo), NaCl, PDNO, Nitrosooxypropanol | Attgeno AB, Vinnova | Pulmonary Hypertension, COVID-19 | 04/23 | 04/23 | | |
| Jonsson, Marcus |
NCT06150131: Exercise Intervention After Lung Cancer Surgery |
|
|
| Recruiting | N/A | 90 | Europe | Exercise | Region Örebro County | Rehabilitation After Lung Cancer Surgery | 06/25 | 06/25 | | |
| Ahlstrand, Erik |
| Recruiting | 3 | 6430 | Europe, RoW | Omitted Doxorubicin, Omitted Vincristine+Dexamethasone pulses, Inotuzumab Ozogamicin+Standard Maintenance Therapy, Besponsa+Maintenance Therapy, Imatinib, 6-tioguanine+Standard Maintenance Therapy, Blinatumomab, Blincyto | Mats Heyman, The Swedish Research Council, The Swedish Childhood Cancer Foundation, Pfizer, Servier, NordForsk, Aamu Pediatric Cancer Foundation, German Society for Pediatric Oncology and Hematology GPOH gGmbH, Clinical Trial Center North (CTC North GmbH & Co. KG), Belgium Health Care Knowledge Centre, Karolinska Institutet, Cancer Research UK, Fundação Rui Osório de Castro, Acreditar - Associação de Pais e Amigos das Crianças com Cancro, Grupo Português De Leucemias Pediátricas, Amgen, Nova Laboratories Limited, Danish Child Cancer Foundation, Danish Cancer Society, The Novo Nordic Foundation, Assistance Publique - Hôpitaux de Paris, Direction Générale de l'Offre de Soins | Leukemia, Acute Lymphoblastic | 06/27 | 06/32 | | |
BosuPeg, NCT03831776: Long-acting Low Dose Ropeginterferon for Chronic Myeloid Leukemia Treated With Bosutinib From Diagnosis |
|
|
| Recruiting | 2 | 212 | Europe | Bosutinib, Ropeginterferon, RoPegIFN | St. Olavs Hospital, Haukeland University Hospital, Oslo University Hospital, University Hospital of North Norway, Helse Stavanger HF, Henri Mondor University Hospital, Hôpital René Huguenin, Hôpital Mignot, Versailles Paris, Uppsala University Hospital, Odense University Hospital | Chronic Myeloid Leukemia | 02/24 | 03/28 | | |
| Frøbert, Ole |
ELIMINATE, NCT06336317: Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE |
|
|
| Recruiting | 4 | 90 | Europe | Influenza vaccine, Placebo | Region Örebro County, The Swedish Heart and Lung Association, Örebro University, Sweden, University of Cambridge | Acute Myocardial Infarction, Cardiovascular Diseases, Inflammatory Response | 12/27 | 12/27 | | |
| Jonsson |
NCT06150131: Exercise Intervention After Lung Cancer Surgery |
|
|
| Recruiting | N/A | 90 | Europe | Exercise | Region Örebro County | Rehabilitation After Lung Cancer Surgery | 06/25 | 06/25 | | |
| Löfgren, David |
TRIANGLE, NCT02858258: ASCT After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell Lymphoma |
|
|
| Recruiting | 3 | 870 | Europe | R-CHOP/R-DHAP, rituximab, CHOP, DHAP, Ibrutinib (Induction), Imbruvica, ASCT conditioning, THAM or BEAM, Ibrutinib (Maintenance) | Prof. Dr. M. Dreyling (co-chairman), LMU Klinikum | Mantle Cell Lymphoma | 05/21 | 05/26 | | |
| Szabó, Barna |
| Recruiting | 3 | 2000 | Europe, US | Spironolactone, Standard care | Uppsala University, Karolinska University, Duke Clinical Research Institute, National Heart, Lung, and Blood Institute (NHLBI) | Heart Failure With Preserved Ejection Fraction | 12/26 | 12/26 | | |
| Dreifaldt, Mats |
| Recruiting | 4 | 2200 | Europe, RoW | Ticagrelor 90mg twice daily and ASA 75-100 mg daily, ASA 75-160 mg daily | Vastra Gotaland Region, Gothia Forum - Center for Clinical Trial, Uppsala University | Acute Coronary Syndrome | 06/25 | 06/31 | | |
| Sundh, Josefin |
| Recruiting | 4 | 1700 | Europe | Metoprolol, Standard care, Usual standard care | Ole Frobert, MD, PhD | Chronic Obstructive Pulmonary Disease | 12/24 | 12/24 | | |
NCT04896853: Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans® |
|
|
| Recruiting | 1 | 9 | Europe | ProTrans® | NextCell Pharma Ab, Karolinska Trial Alliance | COVID-19 Acute Respiratory Distress Syndrome, Influenza A, Metapneumovirus Pneumonia, Respiratory Syncytial Virus (RSV) | 09/24 | 12/24 | | |
| Recruiting | N/A | 310 | Europe | Added high-flow oxygen therapy, Standard care | Skane University Hospital, Uppsala University Hospital, Region Stockholm, Region Örebro County, Blekinge County Council Hospital, Blekinge Institute of Technology, Lund University, Region Östergötland, Vastra Gotaland Region, Region Västerbotten, Landstinget i Värmland, ResMed, Swedish Heart Lung Foundation, The Swedish Research Council | Chronic Obstructive Pulmonary Disease Severe, Interstitial Lung Disease, Chronic Respiratory Failure With Hypoxia | 12/27 | 12/28 | | |
| Björeman, Mats |
DASTOP2, NCT03573596: Persistence of MR3 in Chronic Myeloid Leukemia (CML) After a 2nd Stop of TKI Treatment |
|
|
| Recruiting | 2 | 134 | Europe | Dasatinib | Amsterdam UMC, location VUmc, Uppsala University Hospital, Skane University Hospital, Helsinki University Central Hospital, Odense University Hospital, Henri Mondor University Hospital, St. Olavs Hospital, Helse Stavanger HF, Aarhus University Hospital, University Hospital, Bonn | CML, Relapsed | 02/23 | 02/24 | | |
| Jildenstål, Pether |
NCT04613154: Magnesium as an Adjunct for Pain Treatment After Surgery for Thumb Base Arthrosis |
|
|
| Terminated | N/A | 9 | Europe | magnesiumcitrate, Placebo | Region Örebro County | Thumb Osteoarthritis | 10/23 | 10/23 | | |
| Recruiting | N/A | 15 | Europe | | Göteborg University | Coronary Syndrome, Pediatric | 06/24 | 12/24 | | |
NCT03697278: Monitoring Postoperative Patient-controlled Analgesia (PCA) |
|
|
| Recruiting | N/A | 90 | Europe | Smith medical CADDsolis, intervention group | Pether Jildenstal, Göteborg University | Postoperative Pain, Patient Controlled Analgesia, Surgery, Nurse-Patient Relations | 10/24 | 12/24 | | |
NCT05218551: Comparison of Different Objective Nociceptive Measurement Methods During Surgery |
|
|
| Recruiting | N/A | 75 | Europe | | Göteborg University | Nociceptive Pain | 10/24 | 11/24 | | |
NCT06322264: Promoting Children's Participation in Conventional X-ray Examinations |
|
|
| Not yet recruiting | N/A | 220 | NA | Measurement of variation in heart rate | Lund University, Skane University Hospital | Heart Rate Determination, Patient Participation | 12/24 | 04/25 | | |
NCT06171477: Regional Distribution of Ventilation at Different Respiratory Rates |
|
|
| Recruiting | N/A | 15 | Europe | Ventilation 20-40-60, Ventilation 60-40-20, Ventilation 40-60-20 | Region Örebro County | Mechanical Ventilation, Atelectasis, Distribution of Ventilation | 06/24 | 12/24 | | |
| Adjedj, Julien |
| Active, not recruiting | N/A | 2001 | Europe | QFR-based diagnostic strategy, FFR-based diagnostic strategy | Aarhus University Hospital Skejby, Medis Medical Imaging Systems | Coronary Artery Disease | 07/23 | 12/25 | | |
| Recruiting | N/A | 140 | Europe | angioplasty | Institut Mutualiste Montsouris, Abbott | Coronary Artery Calcification, Angioplasty | 12/23 | 12/23 | | |
TRIESTE, NCT04317846: Transradial Evaluation Study of Diameter Increase After Vasodilatory Drugs Administration. |
|
|
| Active, not recruiting | N/A | 165 | Europe | Intravenous administration of vasodilatory drugs | University of Lausanne Hospitals, Centre de recherche clinique - FBM-CHUV | Arterial Spasm, Coronary Artery Disease | 03/24 | 06/24 | | |
BEST, NCT05454150: Balloon-Expandable Versus Self-expanding Transcatheter Heart Valve for Treatment of Symptomatic Native Aortic Valve Stenosis |
|
|
| Recruiting | N/A | 1862 | Europe | balloon-expandable valve, self-expanding valve | University Hospital, Lille, Ministry of Health, France | Aortic Valve Stenosis | 07/25 | 07/25 | | |
| Ström, Jakob |
NCT03812666: Search for Biomarkers of Infection and Inflammation in Patients With Acute Stroke. |
|
|
| Active, not recruiting | N/A | 200 | Europe | | Jakob Ström, Örebro University, Sweden | Stroke, Acute, Pneumonia, Bacterial | 07/23 | 07/25 | | |
| Lundin, Erik |
MARS, NCT04530708: Addition of Radiotherapy to Standard Medical Treatment for Stage IV NSCLC |
|
|
| Recruiting | 3 | 162 | Europe | Thoracic radiotherapy | Swedish Lung Cancer Study Group | Radiotherapy, Non Small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer, Quality of Life | 02/24 | 02/26 | | |
ARTSCAN VI, NCT06248996: a Multicentre Phase III Study of Risk-based Treatment Intensification With Hyperfractionated Radiotherapy in Head and Neck Cancer Patients |
|
|
| Recruiting | 3 | 308 | Europe | Hyperfractionated radiotherpy, HFX-RT, Control group, standard treatment | Lund University Hospital | Head and Neck Squamous Cell Carcinoma | 03/28 | 03/33 | | |
| Recruiting | 2 | 40 | Europe | Proton radiation | Ass. Prof. Jan Nyman | Cardiotoxicity, Pulmonary Toxicity, Thymus Neoplasms | 04/26 | 04/29 | | |
| Recruiting | N/A | 100 | Europe | Radiotherapy | Lund University Hospital | Tonsil Cancer | 01/28 | 01/28 | | |
| Nordenskjöld, Anna M |
NCT04666454: BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome. |
|
|
| Recruiting | 4 | 1000 | Europe | Adenosine, Dipyridamole 200 mg, Apixaban 5 mg Oral Tablet, Care as recommended by the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology for takotsubo syndrome | Vastra Gotaland Region, Göteborg University | Takotsubo Syndrome | 12/28 | 12/28 | | |
| Active, not recruiting | N/A | 466 | Europe | | Örebro University, Sweden | Influenza, Human, Myocardial Injury | 04/22 | 12/23 | | |
NCT04101149: Genetic Causes of Familial Hypercholesterolemia |
|
|
| Recruiting | N/A | 150 | Europe | No intervention | Region Örebro County | Familial Hypercholesterolemia | 12/25 | 12/45 | | |
| Örtegren, Joakim |
| Recruiting | N/A | 2000 | Europe | Active surveillance | Uppsala University | Prostate Cancer | 12/34 | 12/34 | | |
